Insulin therapies have evolved to the point where Drs. Frederick Banting and Charles Best would hardly recognize their own discovery. With the advent of modern recombinant DNA technology, scientists have developed insulin analogs that better mimic the body's normal insulin action. Now, more predictable basal and bolus insulin therapies help achieve tighter glucose control.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.